Wei Wu
Impact in
- Pharmaceutical Science top 0.01%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 96
- Drug Solubulity and Delivery Systems 80
- Advancements in Transdermal Drug Delivery 39
- Biomaterials 58
- Nanoparticle-Based Drug Delivery 51
- Co-authors
- Yi Lü (173 shared papers)Jianping Qi (123 shared papers)Zhongjian Chen (39 shared papers)Haisheng He (50 shared papers)Weili Zhao (37 shared papers)Quangang Zhu (28 shared papers)Xiaochun Dong (33 shared papers)Fuqiang Hu (13 shared papers)
- Journals
- International Journal of Pharmaceutics (30 papers)Acta Pharmaceutica Sinica B (18 papers)Chinese Chemical Letters (14 papers)Drug Discovery Today (11 papers)International Journal of Nanomedicine (11 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Wei Wu
377 papers receiving 15.5k citations
Wei Wu's Hit Papers
Peers
Comparison fields: 5 of 190
- Pharmaceutical Science 5.6k
- Biomaterials 3.2k
- Molecular Medicine 460
- Pharmacology 557
- Molecular Biology 4.3k
Countries citing papers authored by Wei Wu
This map shows the geographic impact of Wei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wu more than expected).
Fields of papers citing papers by Wei Wu
This network shows the impact of papers produced by Wei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wu. The network helps show where Wei Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 385 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Functionalized Carbon Nanotubes Are Non-Cytotoxic and Preserve the Functionality of Primary Immune Cells Hit paper breakdown → | 2006 | 607 |
| 2 | Adapting liposomes for oral drug delivery Hit paper breakdown → | 2018 | 560 |
| 3 | 2011 | 284 | |
| 4 | Oral delivery of proteins and peptides: Challenges, status quo and future perspectives Hit paper breakdown → | 2021 | 280 |
| 5 | 2006 | 259 | |
| 6 | 2009 | 251 | |
| 7 | 2019 | 251 | |
| 8 | 2012 | 217 | |
| 9 | 2021 | 178 | |
| 10 | 2013 | 178 | |
| 11 | 2016 | 176 | |
| 12 | 2019 | 174 | |
| 13 | 2016 | 173 | |
| 14 | 2013 | 168 | |
| 15 | 2012 | 167 | |
| 16 | 2013 | 165 | |
| 17 | 2020 | 160 | |
| 18 | 2012 | 157 | |
| 19 | Current research trends of nanomedicines Hit paper breakdown → | 2023 | 156 |
| 20 | 2011 | 154 |
About Wei Wu
Wei Wu is a scholar working on Pharmaceutical Science, Biomaterials, Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 385 papers that have together received 16.0k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (96 papers), Drug Solubulity and Delivery Systems (80 papers), Nanoparticle-Based Drug Delivery (51 papers), Advancements in Transdermal Drug Delivery (39 papers), Surfactants and Colloidal Systems (20 papers), RNA Interference and Gene Delivery (19 papers), Lipid Membrane Structure and Behavior (18 papers) and Drug Transport and Resistance Mechanisms (17 papers). The work is most often cited by research in Pharmaceutical Science (5.6k citations), Biomaterials (3.2k citations), Molecular Medicine (460 citations), Pharmacology (557 citations) and Molecular Biology (4.3k citations). Wei Wu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yi Lü, Jianping Qi, Zhongjian Chen, Haisheng He, Weili Zhao, Quangang Zhu, Xiaochun Dong, Fuqiang Hu, Wei He and Xingwang Zhang. Their work appears in journals such as International Journal of Pharmaceutics, Acta Pharmaceutica Sinica B, Chinese Chemical Letters, Drug Discovery Today and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.